Nanomedicine strategies for heating “cold” ovarian cancer (OC): next evolution in immunotherapy of OC

Y Yang, T Zhao, Q Chen, Y Li, Z Xiao… - Advanced …, 2022 - Wiley Online Library
Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …

[HTML][HTML] Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies

B Bortot, A Mangogna, G Di Lorenzo, G Stabile… - Journal of …, 2023 - Springer
Surgical resection is the cornerstone of solid tumour treatment. Current techniques for
evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative …

[HTML][HTML] Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities

MB Parsa, F Tafvizi, V Chaleshi, M Ebadi - Heliyon, 2023 - cell.com
Ovarian cancer stands as a leading cause of cancer-related deaths among women globally.
This malignancy has hindered successful treatment attempts due to its inherent resistance to …

[HTML][HTML] Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell …

B Bortot, M Apollonio, G Baj, L Andolfi, L Zupin… - Free Radical Biology …, 2022 - Elsevier
Photodynamic therapy (PDT) is a potential synergistic approach to chemotherapy for treating
ovarian cancer, the most lethal gynecologic malignancy. Here we used M13 bacteriophage …

[HTML][HTML] The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation

H Wang, L Fang, J Jiang, Y Kuang, B Wang… - Cell death & …, 2018 - nature.com
As a component of p53-dependent lncRNA (long non-coding RNA), PANDAR (the promoter
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …

Actively targeted nanocarriers for drug delivery to cancer cells

S Biffi, R Voltan, B Bortot, G Zauli… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Progressive breakthroughs in nanomedicine have been instrumental for the
clinical translation of actively targeted drug-delivery approaches. Besides storing large …

[HTML][HTML] Characterization of antimicrobial, antioxidant, and leishmanicidal activities of Schiff base derivatives of 4-aminoantipyrine

R Teran, R Guevara, J Mora, L Dobronski… - Molecules, 2019 - mdpi.com
Our main interest is the characterization of compounds to support the development of
alternatives to currently marketed drugs that are losing effectiveness due to the development …

Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer

P Sharma, K Patnala, N Sah, VK Deb, N Gopal… - Process …, 2023 - Elsevier
Ovarian cancer occurs through the proliferation of cells at gynaecological sites and is the
major cause of demise in women. One of the conventional treatments for ovarian cancer is …

[HTML][HTML] Circular PVT1 regulates cell proliferation and invasion via miR-149-5p/FOXM1 axis in ovarian cancer

M Li, C Chi, L Zhou, Y Chen, X Tang - Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) is a dysregulated gene
in malignancy and is associated with oncogenesis. In this study, we found PVT1 RNA was …

[HTML][HTML] Photodynamic therapy using a new folate receptor-targeted photosensitizer on peritoneal ovarian cancer cells induces the release of extracellular vesicles …

M Baydoun, O Moralès, C Frochot, C Ludovic… - Journal of Clinical …, 2020 - mdpi.com
Often discovered at an advanced stage, ovarian cancer progresses to peritoneal carcinoma,
which corresponds to the invasion of the serosa by multiple tumor implants. The current …